(S1 (S (S (NP (NN Brick1)) (VP (VBZ is) (NP (NP (DT an) (JJ essential) (NN regulator)) (PP (IN of) (NP (NN actin) (NN cytoskeleton))) (VP (VBN required) (PP (IN for) (NP (NP (JJ embryonic) (NN development)) (CC and) (NP (NN cell) (NN transformation)))))))) (. .)))
(S1 (S (S (NP (NP (NN Brick1)) (PRN (-LRB- -LRB-) (NP (NN Brk1)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT the) (JJ less-studied) (NN component)) (PP (IN of) (NP (NP (DT the) (JJ Wave/Scar) (NN pathway)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (JJ branched) (NN nucleation)) (PP (IN of) (NP (NN actin) (NNS fibers))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ clinical) (NN relevance)) (PP (IN of) (NP (NN Brk1)))) (VP (VBZ is) (VP (VBN emphasized) (PP (IN by) (NP (NP (JJ correlative) (NNS data)) (VP (VBG showing) (SBAR (IN that) (S (NP (NP (NP (NP (NN Von) (NN Hippel-Lindau)) (PRN (-LRB- -LRB-) (NP (NN VHL)) (-RRB- -RRB-))) (NNS patients)) (SBAR (WHNP (WDT that)) (S (ADVP (RB also)) (VP (VB lose) (NP (DT the) (NN BRK1) (NN gene)))))) (VP (VBP are) (VP (VBN protected) (PP (IN against) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS tumors))))))))))))))) (. .)))
(S1 (S (S (NP (DT This)) (VP (VBZ contrasts) (PP (IN with) (NP (NP (JJ recent) (NN evidence)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT the) (NN Wave) (NN complex)) (VP (MD may) (VP (VB function) (PP (IN as) (NP (NP (DT an) (NN invasion) (NN suppressor)) (PP (IN in) (NP (JJ epithelial) (NNS cancers)))))))))))))) (. .)))
(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (NN downregulation)) (PP (IN of) (NP (NN Brk1)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (JJ abnormal) (NN actin) (NN stress) (NN fiber) (NN formation)) (CC and) (NP (NN vinculin)) (NP (NN distribution))) (CC and) (NP (NP (NN loss)) (PP (IN of) (NP (NP (NN Arp2/3)) (CC and) (NP (NN Wave) (NNS proteins)))) (PP (IN at) (NP (DT the) (JJ cellular) (NNS protrusions)))))))))) (. .)))
(S1 (S (S (NP (NN Brk1)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NP (NN cell) (NN proliferation)) (CC and) (NP (NN cell) (NN transformation))) (PP (IN by) (NP (NNS oncogenes)))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN Brk1) (NN downregulation)) (VP (VBZ results) (PP (PP (IN in) (NP (NP (NP (JJ defective) (JJ directional) (NN migration)) (CC and) (NP (JJ invasive) (NN growth))) (PP (IN in) (NP (NP (JJ renal) (NN cell) (NN carcinoma)) (NNS cells))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (JJ other) (NN tumor) (NN cell) (NNS types)))))) (. .)))
(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (NP (JJ genetic) (NN ablation)) (PP (IN of) (NP (NN Brk1)))) (VP (VBZ results) (PP (IN in) (NP (NP (JJ dramatic) (NNS defects)) (PP (IN in) (NP (NP (NN embryo)) (NP (NN compaction)) (CC and) (NP (NN development)))))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT an) (JJ essential) (NN role)) (PP (IN for) (NP (DT this) (NN protein))) (PP (IN in) (NP (NN actin) (NNS dynamics)))))))) (. .)))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (JJ genetic) (NN loss)) (CC or) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN BRK1))))) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (ADJP (JJ protective) (PP (IN against) (NP (NP (NN tumor) (NN development)) (ADJP (JJ due) (PP (TO to) (NP (NP (NP (NP (NN proliferation)) (CC and) (NP (NN motility))) (NNS defects)) (PP (IN in) (NP (JJ affected) (NNS cells))))))))))))))) (. .)))
